A PROVEN PLATFORM.
QUALITY OUTCOMES.
QUALITY OUTCOMES.
CyberKnife’s precise delivery allows the expansion of radiosurgery and SBRT treatments to indications not possible to treat on other radiation therapy systems.
Page 1 of 1
CLINICAL STUDY
LARGEST CLINICAL STUDIES TO DATE* SUPPORT CYBERKNIFE® SBRT FOR LOCALIZED PROSTATE CANCER
Read about two large prospective, multi-institutional and CyberKnife® System only clinical studies report excellent clinical outcomes at
five years post-treatment.
CLINICAL STUDY
PROVEN SAFETY AND EFFICACY OF THE CYBERKNIFE® SYSTEM FOR THE TREATMENT OF TRIGEMINAL NEURALGIA
Summary of a prospective clinical study that shows Cyberknife performs effectively & comparability to Gamma Knife for treating Trigeminal Neuralgia, but with better patient comfort.
CLINICAL STUDY
Treating inoperable early stage lung cancer with the CyberKnife® System
The purpose of this study is to assess the short and long-term outcomes after CyberKnife stereotactic radiosurgery for early stage non-small cell lung cancer (NSCLC) in patients who are medically inoperable. Treating liver metastases from colorectal cancer with the CyberKnife System. This prospective, multicenter study is intended to establish the efficacy and toxicity of treating […]
CLINICAL STUDY
Prostate Advances in Comparative Evidence (PACE)
This study is an international multicenter randomized study of organ confined low and intermediate risk prostate cancer and is composed of two parallel randomization schemes based on applicability of surgery as a treatment for the patient. Patients for whom surgery is a consideration are randomized to either laparoscopic or da Vinci prostatectomy or CyberKnife prostate […]
